Our findings suggest that KHDRBS3 promotes glycolysis and malignant progression of HCC through upregulating 14-3-3ζ expression, providing a possible target for HCC therapy.
over 2 years ago
Journal
|
KHDRBS3 (KH RNA Binding Domain Containing, Signal Transduction Associated 3) • YWHAZ (Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta)